|
Media Contact: David Addis Senior Vice President, Brand Communication Medimetriks Pharmaceuticals, Inc. Phone: 973-882-7512, ext. 569363 Route 46 West Fairfield, NJ 07004 Fax: 973-882-7502 Email: This email address is being protected from spam bots, you need Javascript enabled to view it |
Recent News PharmaMar licenses Kahalalide F to MedimetriksPharmaMar SA (Grupo Zeltia, ZEL.MC) and Medimetriks Pharmaceuticals, Inc. (Fairfield, NJ) today announced a license agreement covering Kahalalide F and two of its analogs for uses outside of Oncology and Neurology. Medimetriks Pharmaceuticals Launches Two New Prescripti... Medimetriks Pharmaceuticals announced today that the Company launched Centany® (mupirocin ointment, 2%) and Uramaxin™ (20% Urea) Foam to its core Dermatology and Podiatry physician audiences. Perrigo Company Appointed Generic Distributor by Medime... Perrigo Company (NASDAQ: PRGO), a leading manufacturer in the generic prescription marketplace, is designated as the Exclusive Authorized Distributor of generic versions of Medimetriks’ branded products in the U.S. Medimetriks Pharmaceuticals Launches Company’s First Pr... Medimetriks Pharmaceuticals, Inc. announced today that the Company launched its first prescription topical therapies into the Dermatology and Podiatry markets. Perrigo Licenses Prescription Brands to Medimetriks Medimetriks Pharmaceuticals announced today that the Company entered into a licensing agreement with Perrigo Company (NASDAQ: PRGO) for the U.S. marketing rights to Centany® Ointment and two prescription keratolytic brands. Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kun... Accomplished Pharmaceutical Executive Joins the Board of Prescription Skincare Company Medimetriks Pharmaceuticals, Inc. Begins Operations Former Bradley Pharmaceuticals Founder and Senior Management Form New Company Specializing in Dermatology and Podiatry Markets Starting Over in the Skin Game Bradley Pharma founder starts new venture Drug Vets Launch New Firm Bradley Pharmaceuticals founder returns with a startup. |